Biography:
Adèle Rivault obtained in 2023 a double master's degree in engineering chemistry from the Ecole Supérieure de Chimie Organique et Minérale (ESCOM, France) and in organic synthesis & pharmaceutical chemistry from the University of Sherbrooke (UdS, Canada). She started an interdisciplinary PhD between the “Diversité Moléculaire, Métabolomique, Synthèse” team in ICN and “Innovative therapies in myeloid leukemia” in C3M to develop new chimeric molecules able to degrade known oncogenic proteins to circumvent resistance mechanisms in leukemias. She obtained an EUR LIFE interdisciplinary thesis grant funded by IDEX (Plan Investissement d'Avenir).
